Paris, France

Chantal Boulanger

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chantal Boulanger: Innovator in Hemolytic Disease Research

Introduction

Chantal Boulanger is a prominent inventor based in Paris, France. She has made significant contributions to the field of medical research, particularly in the treatment of hemolytic diseases. With a total of 2 patents, her work focuses on innovative methods for diagnosing and preventing complications associated with sickle cell disease and cirrhosis.

Latest Patents

Chantal Boulanger's latest patents include groundbreaking methods for treating vaso-occlusive crises using non-modified annexin V. This invention outlines a method for determining the risk of severe complications in hemolytic diseases. It involves assessing the levels of cell microparticles in a blood sample from patients suffering from sickle cell disease. Additionally, her patent details a method for preventing vaso-occlusive crises by depleting blood-borne microparticles laden with heme and hemoglobin.

Another significant patent focuses on methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension. This method quantifies various microparticles in a blood sample and compares them with predetermined reference values to assess risk.

Career Highlights

Chantal Boulanger has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. Her research has been instrumental in advancing the understanding and treatment of complex medical conditions.

Collaborations

Throughout her career, Chantal has collaborated with notable colleagues, including Olivier Blanc-Brude and Pierre-Louis Tharaux. These partnerships have further enriched her research and contributed to her innovative approaches in the medical field.

Conclusion

Chantal Boulanger's contributions to medical research exemplify the impact of innovation in addressing critical health challenges. Her patents reflect a commitment to improving patient outcomes in hemolytic diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…